source
- FDA clears Freenome's SimpleScreen CRC blood test, Abbott to market it in U.S.The U.S. Food and Drug Administration has given clearance to Freenome’s SimpleScreen CRC, a blood-based test for colorectal cancer. Abbott will be the exclusive U.S. marketer and will pay Freenome…
- Global HIV funding drops 18%, raising fears of epidemic resurgenceA new UNAIDS report warns that the world could see a rebound of HIV infections after donor financing fell sharply last year. Government contributions dropped by more than $1.5 billion to $7.3 bill…